STAAR Surgical Company STAA
NASDAQ
| 10/02/2026 | 07/03/2026 | 04/03/2026 | 01/02/2026 | 09/26/2025 | |
|---|---|---|---|---|---|
| Revenue | 328.27M | 339.59M | 290.38M | 239.44M | 230.59M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 328.27M | 339.59M | 290.38M | 239.44M | 230.59M |
| Cost of Revenue | 86.81M | 79.39M | 67.10M | 57.02M | 60.26M |
| Gross Profit | 241.46M | 260.20M | 223.27M | 182.42M | 170.33M |
| SG&A Expenses | 179.59M | 180.62M | 178.21M | 188.10M | 192.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 305.97M | 298.33M | 283.95M | 285.18M | 293.27M |
| Operating Income | 22.30M | 41.26M | 6.42M | -45.74M | -62.68M |
| Income Before Tax | 5.57M | 17.38M | -19.56M | -82.26M | -91.95M |
| Income Tax Expenses | 5.04M | 13.54M | 1.47M | -1.82M | 4.42M |
| Earnings from Continuing Operations | 0.53 | 3.84 | -21.03 | -80.45 | -96.37 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 530.00K | 3.84M | -21.03M | -80.45M | -96.37M |
| EBIT | 22.30M | 41.26M | 6.42M | -45.74M | -62.68M |
| EBITDA | 31.24M | 49.76M | 14.51M | -37.42M | -53.99M |
| EPS Basic | 0.01 | 0.08 | -0.42 | -1.63 | -1.95 |
| Normalized Basic EPS | 0.33 | 0.56 | 0.16 | -0.46 | -0.74 |
| EPS Diluted | 0.00 | 0.07 | -0.43 | -1.63 | -1.96 |
| Normalized Diluted EPS | 0.33 | 0.55 | 0.15 | -0.47 | -0.74 |
| Average Basic Shares Outstanding | 200.53M | 199.62M | 198.82M | 198.26M | 197.76M |
| Average Diluted Shares Outstanding | 203.61M | 202.71M | 200.73M | 199.17M | 198.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |